Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications.

Muneer A.

Clin Psychopharmacol Neurosci. 2017 May 31;15(2):100-114. doi: 10.9758/cpn.2017.15.2.100. Review.

2.

Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses.

Kim Y, Zhang Y, Pang K, Kang H, Park H, Lee Y, Lee B, Lee HJ, Kim WK, Geum D, Han K.

Exp Neurobiol. 2016 Dec;25(6):296-306. doi: 10.5607/en.2016.25.6.296. Epub 2016 Oct 28.

3.

Altered Translational Control of Fragile X Mental Retardation Protein on Myelin Proteins in Neuropsychiatric Disorders.

Jeon SJ, Ryu JH, Bahn GH.

Biomol Ther (Seoul). 2017 May 1;25(3):231-238. doi: 10.4062/biomolther.2016.042. Review.

4.

Circulating Plasma Micro RNAs in Patients with Major Depressive Disorder Treated with Antidepressants: A Pilot Study.

Enatescu VR, Papava I, Enatescu I, Antonescu M, Anghel A, Seclaman E, Sirbu IO, Marian C.

Psychiatry Investig. 2016 Sep;13(5):549-557. Epub 2016 Sep 30.

5.

The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression.

Azevedo JA, Carter BS, Meng F, Turner DL, Dai M, Schatzberg AF, Barchas JD, Jones EG, Bunney WE, Myers RM, Akil H, Watson SJ, Thompson RC.

J Psychiatr Res. 2016 Nov;82:58-67. doi: 10.1016/j.jpsychires.2016.07.012. Epub 2016 Jul 18.

PMID:
27468165
6.

Turing Revisited: Decoding the microRNA Messages in Brain Extracellular Vesicles for Early Detection of Neurodevelopmental Disorders.

Gillet V, Hunting DJ, Takser L.

Curr Environ Health Rep. 2016 Sep;3(3):188-201. doi: 10.1007/s40572-016-0093-0. Review.

PMID:
27301443
7.

Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder.

Wang Q, Dwivedi Y.

World J Biol Psychiatry. 2016 Jul 11:1-12. [Epub ahead of print]

PMID:
27269743
8.

The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.

Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, Bhattacharjee A, Brennand KJ, Burdick KE, Calabrese JR, Calkin CV, Claasen A, Coryell WH, Craig D, DeModena A, Frye M, Gage FH, Gao K, Garnham J, Gershon E, Jakobsen P, Leckband SG, McCarthy MJ, McInnis MG, Maihofer AX, Mertens J, Morken G, Nievergelt CM, Nurnberger J, Pham S, Schoeyen H, Shekhtman T, Shilling PD, Szelinger S, Tarwater B, Yao J, Zandi PP, Kelsoe JR.

BMC Psychiatry. 2016 May 5;16:129. doi: 10.1186/s12888-016-0732-x.

9.

Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways.

Doeppner TR, Kaltwasser B, Sanchez-Mendoza EH, Caglayan AB, Bähr M, Hermann DM.

J Cereb Blood Flow Metab. 2017 Mar;37(3):914-926. doi: 10.1177/0271678X16647738. Epub 2016 Jul 21.

PMID:
27126323
10.

Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.

Alural B, Genc S, Haggarty SJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:87-103. doi: 10.1016/j.pnpbp.2016.03.010. Epub 2016 Apr 9.

PMID:
27072377
11.

Multiplexed Intact-Tissue Transcriptional Analysis at Cellular Resolution.

Sylwestrak EL, Rajasethupathy P, Wright MA, Jaffe A, Deisseroth K.

Cell. 2016 Feb 11;164(4):792-804. doi: 10.1016/j.cell.2016.01.038.

12.

Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation.

Brites D, Fernandes A.

Front Cell Neurosci. 2015 Dec 17;9:476. doi: 10.3389/fncel.2015.00476. eCollection 2015. Review.

13.

Scriptaid Treatment Decreases DNA Methyltransferase 1 Expression by Induction of MicroRNA-152 Expression in Porcine Somatic Cell Nuclear Transfer Embryos.

Liang S, Zhao MH, Choi JW, Kim NH, Cui XS.

PLoS One. 2015 Aug 11;10(8):e0134567. doi: 10.1371/journal.pone.0134567. eCollection 2015.

14.

Circulating microRNA-144-5p is associated with depressive disorders.

Wang X, Sundquist K, Hedelius A, Palmér K, Memon AA, Sundquist J.

Clin Epigenetics. 2015 Jul 22;7:69. doi: 10.1186/s13148-015-0099-8. eCollection 2015.

15.

Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells.

Alural B, Ozerdem A, Allmer J, Genc K, Genc S.

Front Cell Neurosci. 2015 May 28;9:209. doi: 10.3389/fncel.2015.00209. eCollection 2015.

16.

Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2.

Fiori E, Babicola L, Andolina D, Coassin A, Pascucci T, Patella L, Han YC, Ventura A, Ventura R.

Behav Genet. 2015 Sep;45(5):547-59. doi: 10.1007/s10519-015-9724-8. Epub 2015 May 31.

17.

Differential expression and clinical significance of three inflammation-related microRNAs in gangliogliomas.

Prabowo AS, van Scheppingen J, Iyer AM, Anink JJ, Spliet WG, van Rijen PC, Schouten-van Meeteren AY, Aronica E.

J Neuroinflammation. 2015 May 20;12:97. doi: 10.1186/s12974-015-0315-7.

18.

Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease.

Kocerha J, Dwivedi Y, Brennand KJ.

Mol Psychiatry. 2015 Jun;20(6):677-84. doi: 10.1038/mp.2015.30. Epub 2015 Mar 31. Review.

19.

SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.

Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein DH, Cascorbi I, Kroetz DL.

Neurobiol Dis. 2015 May;77:127-40. doi: 10.1016/j.nbd.2015.02.025. Epub 2015 Mar 10.

20.

Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder.

Wan Y, Liu Y, Wang X, Wu J, Liu K, Zhou J, Liu L, Zhang C.

PLoS One. 2015 Mar 12;10(3):e0121975. doi: 10.1371/journal.pone.0121975. eCollection 2015.

Supplemental Content

Support Center